GRAIL, LLC., a healthcare company whose mission is to detect cancer early when it can be cured, today will host a virtual Capital Markets Day. Members from GRAIL’s management team will outline growth drivers for Galleri®, a clinically validated, commercially available multi-cancer early detection test, as well as the Company’s scientific expertise, addressable market opportunity, business strategy, and financial profile. GRAIL’s presenters will include Bob Ragusa, Chief Executive Officer, Aaron Freidin, Chief Financial Officer, Joshua Ofman MD, MSHS, President, and Sir Harpal Kumar,...